Clinical Trial Update: An Observational Study of Avastin (Bevacizumab) in Combination With Xeloda (Capecitabine) And Oxaliplatin in Patients With Colorectal Cancer

View source ↗

Summary

An observational clinical trial evaluating bevacizumab in combination with capecitabine and oxaliplatin in colorectal cancer has completed and posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Avastin (bevacizumab)
• Eloxatin (oxaliplatin)
• Xeloda (capecitabine)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Colorectal Cancer | Status: COMPLETED | Results posted: 2016-09-28